WASHINGTON, DC - FEBRUARY 08: U.S. Sen. Bernie Sanders (I-VT), Chairman of the Senate Health, Education, Labor, and Pensions Committee, presides over a hearing on prescription drugs costs at the Dirksen Senate Office Building on February 08, 2024 in Washington, DC. The Committee heard testimony on drug pricing from the heads of several drug manufactures including Joaquin Duato, CEO of Johnson & Johnson, Robert Davis, CEO of Merck, and Chris Boerner, CEO of Bristol Myers Squibb.